Filtered By:
Drug: Aspirin
Management: Health Insurance
This page shows you your search results in order of date.
Order by Relevance | Date
Total 37 results found since Jan 2013.
Association between eupatilin and reduction in small bowel bleeding in aspirin users and aspirin plus acid suppressant users
CONCLUSIONS: Eupatilin was associated with a reduced risk of SB bleeding in both aspirin users and those with concomitant use of acid suppressants. Eupatilin use should be considered for aspirin users, especially for those concomitantly taking acid suppressants.PMID:37198878 | DOI:10.3904/kjim.2022.340
Source: The Korean Journal of Internal Medicine - May 18, 2023 Category: Internal Medicine Authors: Hyun Seok Lee Ji Hyung Nam Dong Jun Oh Hyun Jung Ahn Yun Jeong Lim Source Type: research
Association between first-step analgesic use and cancer in patients with diabetes
CONCLUSION: Regular use of analgesics by patients with diabetes decreased their risk of subsequent cancer development in this large national cohort. Compared with participants who did not develop cancer, those with cancer were older and more likely to be male, did not exercise, have more comorbidities (as assessed by CCI), and did not use analgesics regularly.PMID:36420887 | DOI:10.5414/CP204305
Source: Clinical Pharmacology and Therapeutics - November 24, 2022 Category: Drugs & Pharmacology Authors: Ie Byung Park Hwa Jeong Seo Source Type: research
Association between metabolic syndrome and colorectal cancer incidence and all-cause mortality: a hospital-based observational study
CONCLUSION: Compared with 1-2 components, subjects with 3-4 MetS components are at greater risk of CRC and death at follow-up. This study also demonstrates the risks for CRC and all-cause mortality in certain subgroups of individuals with 3-4 MetS components compared to 1-2 components. These findings may help clinicians on the CRC risk stratification according to individuals' characteristics, as well as to optimize the strategy of MetS surveillance and control in order to prevent CRC.PMID:36368935 | DOI:10.1186/s12876-022-02505-5
Source: Cancer Control - November 11, 2022 Category: Cancer & Oncology Authors: Kuan-Chih Chung Sin-Ei Juang Hong-Hwa Chen Kung-Chuan Cheng Kuen-Lin Wu Ling-Chiao Song Ko-Chao Lee Source Type: research
Cost-Effectiveness of Vonoprazan Compared With Proton Pump Inhibitors in Patients Taking Low-Dose Aspirin for Secondary Prevention of Cardiovascular Events in Japan
CONCLUSIONS: Vonoprazan is dominant or cost-effective compared with esomeprazole and lansoprazole in patients taking LDA for secondary prevention of CV events.PMID:36002313 | DOI:10.1253/circj.CJ-22-0127
Source: Circulation Journal - August 24, 2022 Category: Cardiology Authors: Masanobu Ishii Takashi Kawai Kenichi Tsujita Ataru Igarashi Manabu Suzuki Hisato Deguchi Jovelle Fernandez Source Type: research
A thrombocytaaggreg áció-gátló kezelés gyakorlata heveny szívinfarktusban
CONCLUSION: The frequency of use of certain antiplatelet drugs varies significantly across different intervention centres. More than three-quarters of the patients are adherent to treatment 1 year after starting treatment. Orv Hetil. 2022; 163(19): 743-749.PMID:35526182 | DOI:10.1556/650.2022.32453
Source: Orvosi Hetilap - May 8, 2022 Category: General Medicine Authors: Andr ás Jánosi Tam ás Ferenci G ábor Bársony Anik ó Szabóné Póth P éter Vajer P éter Andréka Source Type: research
